Table 3 Univariate analysis of disease-free survival

From: Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy

Variable

3-year DFS (%)

P -value

Sex

Male

85.0

0.66

Female

83.8

 

Age

⩾65 years

85.7

0.82

<65 years

83.9

 

Location

Proximal

87.0

0.25

Distal

83.1

 

Stage

II

86.8

0.35

III

84.1

 

T stage

T1–3

86.8

0.003

T4

73.9

 

N stage

N0–1

89.4

<0.001

N2

72.6

 

Angiolymphatic invasion

Present

75.4

<0.001

Absent

91.2

 

Venous invasion

Present

71.0

0.003

Absent

86.6

 

Perineural invasion

Present

74.3

<0.001

Absent

87.8

 

Histology

MAC

57.4

<0.001

Non-MAC*

86.3

 

Microsatellite status

MSS/MSI-L

84.1

0.46

MSI-H

90.0

 
  1. Abbreviations: DFS=disease-free survival; MAC=mucinous adenocarcinoma; MSI-H=high microsatellite instability; MSI-L=low microsatellite instability; MSS=microsatellite stable.
  2. *Non-MAC includes non-mucinous adenocarcinoma and adenocarcinoma with intermediate mucinous component.
Back to article page